Lipika Goyal,¹ Funda Meric-Bernstam,² Antoine Hollebecque,³ Chigusa Morizane,⁴ Juan W. Valle,⁵ Thomas B. Karasic,⁶ Thomas A. Abrams,⁷ Robin Kate Kelley,⁸ Philippe Cassier,⁹ Junji Furuse,¹⁰ Heinz-Josef Klümpen,¹¹ Heung-Moon Chang,¹² Li-Tzong Chen,¹³ Yoshito Komatsu,¹⁴ Kunihiro Masuda,¹⁵ Daniel Ahn,¹⁶ Yaohua He,¹⁷ Nital Soni,¹⁷ Karim A. Benhadji,¹⁷ John A. Bridgewater¹⁸

¹Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA; ²University of Texas MD Anderson Cancer Center, Houston, TX, USA; ³Drug Development, Institut Gustave Roussy, Villejuif, France; ⁴National Cancer Center Hospital, Tokyo, Japan; ⁵University of Manchester and The Christie NHS Foundation Trust, Manchester, UK; ⁶Hospital of the University of Pennsylvania, Philadelphia, PA, USA; ⁷Dana-Farber Cancer Institute, Boston, MA, USA; ⁸University of California, San Francisco, CA, USA; ⁹Centre Léon-Bérard, Lyon, France; ¹⁰Kyorin University, Faculty of Medicine, Tokyo, Japan; ¹¹Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands; ¹²Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea; ¹³National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan; ¹⁴Division of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Hokkaido, Japan; ¹⁵Tohoku University Graduate School of Medicine, Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan; ¹⁶Mayo Clinic, Phoenix, AZ, USA; ¹⁷Taiho Oncology, Inc., Princeton, NJ, USA; ¹⁸UCL Cancer Institute, London, UK